Ajay K. Singh, MBBS, FRCP, MBA

Articles by Ajay K. Singh, MBBS, FRCP, MBA

Cardiovascular-Kidney-Metabolic Syndrome: A New Look for an Old Syndrome

Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | November 13, 2023

SGLT2i therapy is contraindicated in patients with type 1 diabetes mellitus (T1DM) who have CKD.

Read More

Support the Chronic Kidney Disease Improvement in Research and Treatment Act (HR 5027)

Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | October 26, 2023

The first part of the dialysis moonshot is to prevent the need for dialysis.

Read More

UACR: Its Time Has Come

Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | September 18, 2023

Measuring eGFR and UACR is a key component of guideline-directed medical therapy for patients with CKD from type 2 diabetes.

Read More

SGLT2 Inhibitors and CKD

Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | August 9, 2023

The most important patients who should receive treatment with SGLT2 inhibitors are those with CKD and type 2 diabetes.

Read More

New Treatment for Lupus Nephritis

Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | December 22, 2020

Editor's Note: ...

Read More